With over 15 years of experience in budget impact analysis for provincial, federal and private drug plans, we offer claims based and epidemiological methodologies and our budget impact models are easy to use by drug plan managers.

We understand the reimbursement environment of each Canadian province as well as the private payer world and we tailor each analysis to their respective market.